GRIFIN
Grifin
Also known as: GRIFN_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A4D1Z8
- Gene
- GRIFIN
- Ensembl
- ENSG00000275572
- Chromosome
- 7
- Canonical length
- 144 aa
- Protein class
- Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to enable carbohydrate binding activity. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
144 residues, UniProt reviewed canonical sequence.
>A4D1Z8|GRIFIN
1 MAVQSKAFCA GGLAPGWKLL VQGHADSGED RFETNFLLET GDIAFHIKPR FSSATVVGNA
61 FQYGRWGPEQ VSSIFPLAPG EPFEIEVSWD AEHFHVYAPE HKVLQFPCRQ RPLGATTRVR
121 VLSDHCLAQV ELAKRGLSWG DRGYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRIFIN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 0.5 nTPM
Expression across tissuesHPA
Tissue
- skin: 0.5 nTPM
- choroid plexus: 0.3 nTPM
- adipose tissue: 0.2 nTPM
- adrenal gland: 0.1 nTPM
- bone marrow: 0.1 nTPM
- hypothalamus: 0.1 nTPM
Single-cell type
- astrocytes: 1 nCPM
- early spermatids: 1 nCPM
- bergmann glia: 0.2 nCPM
- retinal bipolar cells: 0.2 nCPM
- ependymal cells: 0.1 nCPM
- smooth muscle cells: 0.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 5 nTPM
- cerebellum: 4.5 nTPM
- medulla oblongata: 4.4 nTPM
- hippocampal formation: 3.7 nTPM
- midbrain: 3.7 nTPM
- pons: 3.5 nTPM
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRIFIN as an antibody target. Whether an autoantibody or antibody against GRIFIN could matter depends on whether native GRIFIN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRIFIN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GRIFIN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...